CIBC Private Wealth Group
ADPT icon

CIBC Private Wealth Group’s Adaptive Biotechnologies ADPT Stock Holding History

CIBC Private Wealth Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$62.4K Hold
3,845
– – ﹤0.01% 1697
2025
Q3 		$57.5K Hold
3,845
– – ﹤0.01% 1733
2025
Q2 		$44.8K Hold
3,845
– – ﹤0.01% 1711
2025
Q1 		$29.5K Hold
3,845
– – ﹤0.01% 1839
2024
Q4 		$25.7K Hold
3,845
– – ﹤0.01% 1952
2024
Q3 		$19.7K Sell
3,845
-1,205
-24% -$5.25K ﹤0.01% 2165
2024
Q2 		$18.2K Hold
5,050
– – ﹤0.01% 2070
2024
Q1 		$15.7K Buy
+5,050
New +$19.5K ﹤0.01% 2121
2022
Q4 		– Sell
-13,460
Closed -$96K – 860
2022
Q3 		$96K Buy
13,460
+1,095
+9% +$10.3K ﹤0.01% 878
2022
Q2 		$100K Buy
12,365
+320
+3% +$2.81K ﹤0.01% 927
2022
Q1 		$167K Buy
12,045
+1,140
+10% +$17.9K ﹤0.01% 972
2021
Q4 		$306K Sell
10,905
-895
-8% -$27.4K ﹤0.01% 874
2021
Q3 		$401K Buy
11,800
+1,000
+9% +$36.2K ﹤0.01% 763
2021
Q2 		$441K Buy
10,800
+900
+9% +$35K ﹤0.01% 819
2021
Q1 		$399K Buy
9,900
+50
+0.5% +$2.71K ﹤0.01% 852
2020
Q4 		$582K Hold
9,850
– – ﹤0.01% 746
2020
Q3 		$479K Buy
+9,850
New +$414K ﹤0.01% 690
2020
Q2 		– Sell
-12,600
Closed -$350K – 592
2020
Q1 		$350K Buy
12,600
+1,100
+10% +$30.7K ﹤0.01% 681
2019
Q4 		$344K Buy
11,500
+1,150
+11% +$33K ﹤0.01% 771
2019
Q3 		$320K Buy
+10,350
New +$422K ﹤0.01% 769

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CIBC Private Wealth Group's ADPT Position: Q4 2025 in Review

CIBC Private Wealth Group held its Adaptive Biotechnologies (ADPT) position steady in Q4 2025 at 3,845 shares worth $62.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1697.

CIBC Private Wealth Group first reported a position in ADPT in Q3 2019 and has held it in 20 quarters since. The position peaked at $582K in Q4 2020. 283 funds tracked by Wall St. Rank hold ADPT as of Q4 2025.

  • CIBC Private Wealth Group held 3,845 shares of Adaptive Biotechnologies worth $62.4K as of Q4 2025.
  • CIBC Private Wealth Group left its Adaptive Biotechnologies share count unchanged in Q4 2025.
  • Adaptive Biotechnologies made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1697 holding.
  • CIBC Private Wealth Group first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 20 quarters since.
  • CIBC Private Wealth Group's Adaptive Biotechnologies position peaked at $582K in Q4 2020.
  • 283 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.